Development and application of an integrated full-sequence gene fluorescence quantitative PCR system for carbapenemase genes blaKPC and blaNDM.

OBJECTIVE: The spread of carbapenemase-producing Enterobacteriaceae (CPE) has become a global concern. Therefore, reliable methods for rapid carbapenemase detection are needed. Molecular methods are faster and offer higher sensitivity and specificity than phenotypic methods. However, conventional PCR assays often target partial sequences, which may miss variants or subtypes. This study aimed to develop a new full-sequence gene fluorescent quantitative PCR system for the detection of blaKPC and blaNDM genes in CPE. METHODS: We first designed full-sequence amplification primers targeting the blaKPC and blaNDM genes and established a full-sequence fluorescence quantitative PCR system. The specificity, sensitivity, and limit of detection of the system were subsequently evaluated. Finally, the performance of the system was assessed using 94 clinical carbapenem-resistant Enterobacterales (CRE) isolates (including 69 Klebsiella pneumoniae and 17 Escherichia coli). RESULTS: The full-sequence fluorescence quantitative PCR system specifically amplified the blaKPC and blaNDM genes, with a limit of detection of 10²CFU/mL for both genes. The system exhibited strong robustness against interference. The sensitivity was 100.00% for both genes; the specificity was 91.30% for blaKPC and 98.41% for blaNDM. The Kappa coefficients for blaKPC and blaNDM were 0.9147 and 0.9761, respectively. The system was also capable of detecting strains harboring the blaKPC-33 and blaKPC-71 variants. CONCLUSIONS: We developed a novel full-sequence fluorescence quantitative PCR detection system for the blaKPC and blaNDM genes, which are the carbapenemase genes with the highest detection rates in clinical settings. This detection method demonstrates high sensitivity, high specificity, and the ability to detect mutant genes.